Triggering liposomal drug release with a lysosomotropic agent

Journal of Pharmaceutical Sciences

Volumn 99, Issue 12, 2010, Pages 5011-5018

  Xiong, Subin ^a,b   Li, Hong ^b   Yu, Bo ^b   Wu, Jun ^b   Lee, Robert J ^b  

^a ZHEJIANG UNIVERSITY OF TECHNOLOGY   (China)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

Cancer; Chloroquine; Controlled release; Daunorubicin; Drug targeting; Endosome; Folate receptor; Folate PEG CHEMS; Liposomes; Pharmacodynamics

Indexed keywords

8 HYDROXYPYRENE 1,3,6 TRISULFONIC ACID TRISODIUM; CHLOROQUINE; DAUNORUBICIN; FOLIC ACID; LIPOSOME; SULFONIC ACID DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CYTOTOXICITY; DRUG MECHANISM; DRUG RELEASE; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; ION EXCHANGE; LYMPHATIC LEUKEMIA; MOUSE; NONHUMAN; PH MEASUREMENT;

EID: 78049522390     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.22210     Document Type: Article

References (28)

1. Peer D, Karp JM, Hong S, Farokhzad OC, Margalit R, Langer R. 2007. Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol 2: 751-760.
2. Torchilin VP. 2005. Recent advances with liposomes as pharmaceutical carriers. Nat Rev Drug Discov 4: 145-160.
3. Junior AD, Mota LG, Nunan EA, Wainstein AJ, Wainstein AP, Leal AS, Cardoso VN, De Oliveira MC. 2007. Tissue distribution evaluation of stealth pH-sensitive liposomal cisplatin versus free cisplatin in Ehrlich tumor-bearing mice. Life Sci 80: 659-664.
4. Xiang G, Wu J, Lu Y, Liu Z, Lee RJ. 2008. Synthesis and evaluation of a novel ligand for folate-mediated targeting liposomes. Int J Pharm 356: 29-36.
5. Pan XQ, Zheng X, Shi G, Wang H, Ratnam M, Lee RJ. 2002. Strategy for the treatment of acute myelogenous leukemia based on folate receptor beta-targeted liposomal doxorubicin combined with receptor induction using all-trans retinoic acid. Blood 100: 594-602.
6. Pan XQ, Lee RJ. 2005. In vivo antitumor activity of folate receptor-targeted liposomal daunorubicin in a murine leukemia model. Anticancer Res 25: 343-346.
7. Lu Y, Wu J, Wu JM, Gonit M, Yang X, Lee A, Xiang G, Li H, Liu S, Marcucci G, Ratnam M, Lee RJ. 2007. Role of formulation composition in folate receptor-targeted liposomal doxorubicin delivery to acute myelogenous leukemia cells. Mol Pharmacol 4: 707-712.
8. Bareford LM, Swaan PW. 2007. Endocytic mechanisms for targeted drug delivery. Adv Drug Deliv Rev 59: 748-758.
9. Inoue J, Ideue R, Takahashi D, Kubota M, Kumazawa Y. 2009. Liposomal glycosphingolipids activate natural killer T cell-mediated immune responses through the endosomal pathway. J Control Release 133: 18-23.
10. Lim HJ, Masin D, Madden TD, Bally MB. 1997. Influence of drug release characteristics on the therapeutic activity of liposomal mitoxantrone. J Pharmacol Exp Ther 281: 566-573.
11. Lim HJ, Parr MJ, Masin D, McIntosh NL, Madden TD, Zhang G, Johnstone S, Bally MB. 2000. Kupffer cells do not play a role in governing the efficacy of liposomal mitoxantrone used to treat a tumor model designed to assess drug delivery to liver. Clin Cancer Res 6: 4449-4460.
12. Adlakha-Hutcheon G, Bally MB, Shew CR, Madden TD. 1999. Controlled destabilization of a liposomal drug delivery system enhances mitoxantrone antitumor activity. Nat Biotechnol 17: 775-779.
13. Lindner LH, Eichhorn ME, Eibl H, Teichert N, Schmitt-Sody M, Issels RD, Dellian M. 2004. Novel temperature-sensitive liposomes with prolonged circulation time. Clin Cancer Res 10: 2168-2178.
14. Elegbede AI, Banerjee J, Hanson AJ, Tobwala S, Ganguli B, Wang R, Lu X, Srivastava DK, Mallik S. 2008. Mechanistic studies on the triggered release of liposomal contents by matrix metalloproteinase-9. J Am Chem Soc 130: 10633-10642.
15. Lindner LH, Hossann M, Vogeser M, Teichert N, Wachholz K, Eibl H, Hiddemann W, Issels RD. 2008. Dual role of hexadecylphosphocholine (miltefosine) in thermosensitive liposomes: Active ingredient and mediator of drug release. J Control Release 125: 112-120.
16. Kim IY, Kang YS, Lee DS, Park HJ, Choi EK, Oh YK, Son HJ, Kim JS. 2009. Antitumor activity of EGFR targeted pH-sensitive immunoliposomes encapsulating gemcitabine in A549 xenograft nude mice. J Control Release 140: 55-60.
17. Kawano K, Onose E, Hattori Y, Maitani Y. 2009. Higher liposomal membrane fluidity enhances the in vitro antitumor activity of folate-targeted liposomal mitoxantrone. Mol Pharmacol 6: 98-104.
18. Onyeji CO, Ogunbona FA. 2001. Pharmacokinetic aspects of chloroquine induced pruritus: Influence of dose and evidence for varied extent of metabolism of the drug. Eur J Pharm Sci 13: 195-201.
19. Jensen PB, Sorensen BS, Sehested M, Grue P, Demant EJ, Hansen HH. 1994. Targeting the cytotoxicity of topoisomerase II-directed epipodophyllotoxins to tumor cells in acidic environments. Cancer Res 54: 2959-2963.
20. Vezmar M, Georges E. 2000. Reversal of MRP-mediated doxorubicin resistance with quinoline-based drugs. Biochem Pharmacol 59: 1245-1252.
21. Zamora JM, Pearce HL, Beck WT. 1988. Physical-chemical properties shared by compounds that modulate multidrug resistance in human leukemic cells. Mol Pharmacol 33: 454-462.
22. Klohs WD, Steinkampf RW. 1988. The effect of lysosomotropic agents and secretory inhibitors on anthracycline retention and activity in multiple drug-resistant cells. Mol Pharmacol 34: 180-185.
23. Lee CM, Tannock IF. 2006. Inhibition of endosomal sequestration of basic anticancer drugs: Influence on cytotoxicity and tissue penetration. Br J Cancer 94: 863-869.
24. Clement NR, Gould JM. 1981. Pyranine (8-hydroxy-1, 3, 6-pyrenetrisulfonate) as a probe of internal aqueous hydrogen ion concentration in phospholipid vesicles. Biochemistry 20: 1534-1538.
25. Biegel CM, Gould JM. 1981. Kinetics of hydrogen ion diffusion across phospholipid vesicle membranes. Biochemistry 20: 3474-3479.
26. Wang X, Jansen G, Fan J, Kohler WJ, Ross JF, Schornagel J, Ratnam M. 1996. Variant GPI structure in relation to membrane-associated functions of a murine folate receptor. Biochemistry 35: 16305-16312.
27. Tomayko MM, Reynolds CP. 1989. Determination of subcutaneous tumor size in athymic (nude) mice. Cancer Chemother Pharmacol 24: 148-154.
28. Yoshimura T, Shono M, Imai K, Hong K. 1995. Kinetic analysis of endocytosis and intracellular fate of liposomes in single macrophages. J Biochem 117: 34-41.